Pathophysiology and Pharmacology of Erythropoietin
| Other Authors: | , , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1992, 1992
|
| Edition: | 1st ed. 1992 |
| Subjects: | |
| Online Access: | |
| Collection: | Springer Book Archives -2004 - Collection details see MPG.ReNa |
Table of Contents:
- List of Contents
- I. Structure and Action
- Structure-Function Relationships of Erythropoietin
- Isoforms of Recombinant Human Erythropoietin
- Activation of the Erythropoietin Receptor in the T3C12 Friend Erythroleukemia Cell Line
- II. Sites and Control of Production
- The Role of Adenosine in Hypoxic Regulation of Kidney Production of Erythropoietin
- Oxygen Shunt Diffusion in Renal Cortex and Its Physiological Link to Erythropoietin Production
- Oxygen Sensing and Erythropoietin mRNA Production in Isolated Perfused Rat Kidneys
- Analysis of Erythropoietin Gene Expression by Means of Competitive Polymerase Chain Reaction
- The Developmental Biology of Erythropoiesis and Erythropoietin: Is Erythropoietin a True Hormone or a Paracrine Factor
- Insulin-like Growth Factor 1 and Erythropoiesis During Growth
- III. Blood Levels in Health and Disease
- Clinical Applicability of the Determination of Erythropoietin
- The Effect of Erythropoietin in Chemotherapy-Induced Anaemia in Patients with Osteosarcoma and Ewing’s Sarcoma
- Erythropoietin in Bone Marrow Transplantation: Pathophysiology and Clinical Use
- Experimental and Clinical Results of Perioperative Treatment with Recombinant Human Erythropoietin
- Cardiological Findings in Patients with End-Stage Renal Failure Under Treatment with Erythropoietin
- Long-Term Treatment with Recombinant Human Erythropoietin in Haemodialysis Patients: Effects on Left Ventricular Performance
- Retinal Hypoxia and Anemia in Chronic Renal Failure: Effect of Erythropoietin
- Experience with Subcutaneous Versus Intravenous Administration of Erythropoietin in Haemodialysis Patients
- Pharmacodynamic Aspects of Recombinant Human Erythropoietin - Long-Term Results in Patients with Hemodialysis Treatment
- Comparison of Three Routes of Administration of Recombinant Human Erythropoietin Expressed in C-127 Mouse Cells
- Peritoneal Permeability in Continuous Ambulatory Peritoneal Dialysis After the Correction of Anemia by Erythropoietin
- V. Primary Hemopoietic Disorders and Chemotherapy
- Serum Erythropoietin Levels in Aplastic Anemia Determined by ELISA
- Serum Erythropoietin in Myelodysplasia Syndromes
- Antigenic Characteristics of Erythropoietin-Dependent and -Independent Erythroid Progenitors in Chronic Myeloproliferative Disorders Defined by Monoclonal Antibodies
- Chemotherapy and Erythropoietin Production
- Production of Erythropoietin During and After Thiamphenicol Treatment Occurs Independently of Peripheral Blood Cell Numbers
- VI. Application of Recombinant Erythropoietin in Non-Renal Anemia
- Effects of Inflammatory Cytokines on the Production of Erythropoietin
- The Use of Recombinant Human Erythropoietin in the Treatment of the Anemia of Chronic Disorders
- Recombinant Human Erythropoietin in the Treatment of Anaemia in Rheumatoid Arthritis
- Erythropoietin in Neoplastic Diseases: Preliminary Results
- Erythropoietin Effects on Acute Anemia Induced by Antineoplastic Therapy in the Case of a Uremic Patient with Lymphoma
- The Therapeutic Effect of Recombinant Human Cytokines (GM-CSF, Interleukin-3, Erythropoietin) in Patients with Myelodysplasia Syndromes
- A Sensitive ELISA for Erythropoietin and Its Application in Various Diseases
- Use of Erythropoietin Radioimmunoassay in Polycythemias
- Effects of Exercise on Plasma Erythropoietin in Natives Living Permanently at High Altitude
- Erythropoietin Concentration in Renal Venous Blood in Patient with Renovascular Hypertension: Is It a Marker of Renal Ischemia
- Serum Erythropoietin Levels in Von Hippel-Lindau Syndrome
- IV. Erythropoietin Replacement in Renal Failure
- Iron Metabolism Under Treatment of Renal Anemia with Recombinant Human Erythropoietin
- Erythropoietin Treatment in Children with Renal Anemia
- Bone Marrow Erythroid Precursor Cytoplasmic Ca2+ and 1, 25-Dihydroxyvitamin D3 Regulate the Response to Human Recombinant Erythropoietin in Uremia: In Vitro and In Vivo Studies
- Dyserythropoietic Abnormalities in Hemodialysis Patients on Long-Term Therapy with Human Recombinant Erythropoietin